Park GM, Lee JH, Choi SW, et al. - Whether additional postdilatation using noncompliant balloons following everolimus‐eluting stent implantation could afford better clinical results was determined in this study with 1,774 patients with coronary artery disease. The participants were randomly allocated to undergo additional high‐pressure postdilatation using noncompliant balloons and moderate‐pressure dilatation using stent balloons following everolimus‐eluting stent implantation. A composite of death, myocardial infarction (MI), stent thrombosis, and target vessel revascularization (TVR) 2 years post-randomization was considered as the primary endpoint. At 2 years, the occurrence of the primary endpoint was reported in 3.6% and 4.4% of patients in the high pressure group and in the moderate pressure group, respectively. Overall, no incremental clinical benefits were achieved with the strategy of routine postdilatation using noncompliant balloons following everolimus‐eluting stent implantation.